These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 8938175)
21. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration]. Ando M Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568 [TBL] [Abstract][Full Text] [Related]
22. Plasma levels of brain natriuretic peptide in patients with cirrhosis. La Villa G; Romanelli RG; Casini Raggi V; Tosti-Guerra C; De Feo ML; Marra F; Laffi G; Gentilini P Hepatology; 1992 Jul; 16(1):156-61. PubMed ID: 1618467 [TBL] [Abstract][Full Text] [Related]
23. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites. Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729 [TBL] [Abstract][Full Text] [Related]
24. Development and application of a urodilatin (CDD/ANP-95-126)-specific radioimmunoassay. Drummer C; Fiedler F; Bub A; Kleefeld D; Dimitriades E; Gerzer R; Forssmann WG Pflugers Arch; 1993 Jun; 423(5-6):372-7. PubMed ID: 8351194 [TBL] [Abstract][Full Text] [Related]
25. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983 [TBL] [Abstract][Full Text] [Related]
26. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Bestle MH; Bie P Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425 [TBL] [Abstract][Full Text] [Related]
27. Plasma atrial natriuretic peptide and renin-aldosterone in patients with cirrhosis and ascites: basal levels, changes during daily activity and nocturnal diuresis. Panos MZ; Anderson JV; Payne N; Langley P; Slater JD; Rees L; Williams R Hepatology; 1992 Jul; 16(1):82-8. PubMed ID: 1535609 [TBL] [Abstract][Full Text] [Related]
28. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion. Goetz K; Drummer C; Zhu JL; Leadley R; Fiedler F; Gerzer R J Am Soc Nephrol; 1990 Dec; 1(6):867-74. PubMed ID: 1966524 [TBL] [Abstract][Full Text] [Related]
29. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis. Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277 [TBL] [Abstract][Full Text] [Related]
30. [ANP in the cirrhotic patient. A clinical contribution]. Parlapiano C; Labellarte A; Primi F; Cervellini P; La Torre F; Paparo SB; Baccarini S; Di Nardo A Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457 [TBL] [Abstract][Full Text] [Related]
32. Dendroaspis natriuretic peptide in hepatic cirrhosis. Fábrega E; Crespo J; Rivero M; Casafont F; Castro B; García-Unzueta MT; Amado JA; Pons-Romero F Am J Gastroenterol; 2001 Sep; 96(9):2724-9. PubMed ID: 11569702 [TBL] [Abstract][Full Text] [Related]
33. Urodilatin excretion and its correlation with sodium excretion in healthy full-term newborn infants. Manganaro R; Mamì C; Mancuso A; Saitta G; Marseglia L; Gemelli M Early Hum Dev; 2006 Oct; 82(10):645-7. PubMed ID: 16530358 [TBL] [Abstract][Full Text] [Related]
34. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver. Jespersen B Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012 [TBL] [Abstract][Full Text] [Related]
35. Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol. Morali GA; Tobe SW; Skorecki KL; Blendis LM Hepatology; 1992 Jul; 16(1):42-8. PubMed ID: 1535608 [TBL] [Abstract][Full Text] [Related]
36. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver]. Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181 [TBL] [Abstract][Full Text] [Related]
38. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites. Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288 [TBL] [Abstract][Full Text] [Related]
39. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis. Tulassay T; Tulassay Z; Rascher W Gastroenterol J; 1990; 50(3):140-3. PubMed ID: 2149634 [TBL] [Abstract][Full Text] [Related]
40. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects. Skorecki KL; Leung WM; Campbell P; Warner LC; Wong PY; Bull S; Logan AG; Blendis LM Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]